Frontiers in Oncology | Cancer Immunity and Immunotherapy

Case Report

Published on 16 Sep 2024

Complete response to disitamab vedotin in HER2-low metastatic endometrial carcinoma: a case report and review of the literature

in Cancer Immunity and Immunotherapy

Hu Feng
Shasha Bi
Shanshan Sun
Hongbo Yang
Haoxing Zhou
Jingjing Mao

Frontiers in Oncology

doi 10.3389/fonc.2024.1367140

1,431 views
1 citation

Original Research

Published on 13 Sep 2024

DSP-0509, a TLR7 agonist, exerted synergistic anti-tumor immunity combined with various immune therapies through modulating diverse immune cells in cancer microenvironment

in Cancer Immunity and Immunotherapy

Yosuke Ota
Ryosaku Inagaki
Kentaro Sumida
Megumi Nakamura
Yasuhiro Nagai
Setsuko Yamamoto

Frontiers in Oncology

doi 10.3389/fonc.2024.1410373

2,018 views
1 citation

Hypothesis and Theory

Published on 06 Sep 2024

Hepatocellular carcinoma cells induce γδ T cells through metabolic reprogramming into tumor-progressive subpopulation

in Cancer Immunity and Immunotherapy

Jinkun Xia
Chaoyu Wang
Biao Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1451650

1,637 views
2 citations

Original Research

Published on 04 Sep 2024

A phase III study to access the safety and efficacy of prolgolimab 250 mg fixed dose administered every 3 weeks versus prolgolimab 1 mg/kg every 2 weeks in patients with metastatic melanoma (FLAT)

in Cancer Immunity and Immunotherapy

Lev Demidov
Galina Kharkevich
Natalia Petenko
Vladimir Moiseenko
Svetlana Protsenko
Tatiana Semiglazova
Anastasia Zimina
Nadezhda Kovalenko
Natalia Fadeeva
Dmitry Kirtbaya

Frontiers in Oncology

doi 10.3389/fonc.2024.1385685

2,095 views
1 citation

Brief Research Report

Published on 02 Sep 2024

KIR2DS2+ NK cells in cancer patients demonstrate high activation in response to tumour-targeting antibodies

in Cancer Immunity and Immunotherapy

Lara V. Graham
Jack G. Fisher
Amber D. P. Doyle
Ben Sale
Luis Del Rio
Albert J. E. French
Neema P. Mayor
Thomas R. Turner
Steven G. E. Marsh
Mark S. Cragg

Frontiers in Oncology

doi 10.3389/fonc.2024.1404051

1,850 views

Editorial

Published on 29 Aug 2024

Editorial: Infectious diseases and cancer: convergence and divergence between bacteria, viruses and helminths

in Cancer Immunity and Immunotherapy

Ana Elena Escorcia-Saucedo
Alberto N. Peón
Aldo Christiaan Jardínez-Vera
Luis I. Terrazas
José L. Medina-Franco

Frontiers in Oncology

doi 10.3389/fonc.2024.1471156

589 views

Perspective

Published on 26 Aug 2024

Intratumoral injection and retention hold promise to improve cytokine therapies for cancer

in Cancer Immunity and Immunotherapy

Karsten Sauer
Kavya Rakhra
Kaida Wu
Naveen K. Mehta
Jennifer S. Michaelson
Patrick A. Baeuerle

Frontiers in Oncology

doi 10.3389/fonc.2024.1456658

2,112 views

Review

Published on 26 Aug 2024

Advances in understanding the role of immune checkpoint LAG-3 in tumor immunity: a comprehensive review

in Cancer Immunity and Immunotherapy

Yingzhe Luo
Xuebin Cai
Biao Yang
Facheng Lu
Cheng Yi
Guoyu Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1402837

2,009 views
3 citations

Study Protocol

Published on 26 Aug 2024

iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimens

in Cancer Immunity and Immunotherapy

Alexander Englisch
Clara Hayn
Susanne Jung
Jonas S. Heitmann
Christopher Hackenbruch
Yacine Maringer
Annika Nelde
Marcel Wacker
Monika Denk
Lisa Zieschang

Frontiers in Oncology

doi 10.3389/fonc.2024.1441625

1,837 views
1 citation

Original Research

Published on 26 Aug 2024

The AST/ALT ratio predicts survival and improves oncological therapy decisions in patients with non-small cell lung cancer receiving immunotherapy with or without radiotherapy

in Cancer Immunity and Immunotherapy

Yanyan Zhang
Jingxin Zhang
Shijie Shang
Jiachun Ma
Fei Wang
Meng Wu
Jinming Yu
Dawei Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1389804

1,421 views

Original Research

Published on 26 Aug 2024

Predicting radiotherapy efficacy and prognosis in tongue squamous cell carcinoma through an in-depth analysis of a radiosensitivity gene signature

in Cancer Immunity and Immunotherapy

Jinzhi Lai
Hainan Yang
Junjun Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1334747

1,172 views

Original Research

Published on 23 Aug 2024

A prognostic nomogram for patients with HR+ mucinous breast carcinoma based on the SEER database and a Chinese cohort study

in Cancer Immunity and Immunotherapy

Huiying Fang
Jian Yue
Hongzhong Li
Tiankuo Luan
Pin Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1444531

1,392 views

Original Research

Published on 20 Aug 2024

Efficacy of PD-1 or PD-L1 inhibitors for the therapy of cervical cancer with varying PD-L1 expression levels: a single-arm meta-analysis

in Cancer Immunity and Immunotherapy

Jie Yang
Haizan Yu
Yilei Zhang
Mingli Zhu
Mengyu Zhang
Qiming Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1454372

999 views
1 citation

Original Research

Published on 19 Aug 2024

Predictive value of peri-chemotherapy hematological parameters for febrile neutropenia in patients with cancer

in Cancer Immunity and Immunotherapy

Hongyuan Jia
Long Liang
Xue Chen
Wenzhong Zha
Wei Diao
Wei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1380195

940 views

Case Report

Published on 16 Aug 2024

Etoposide, cisplatin, and sintilimab combined with anlotinib in successful treatment of adrenocortical carcinoma with lung metastasis: a case report

in Cancer Immunity and Immunotherapy

Wenjing Niu
Haimei Zhang
Xuezhen Ma
Hua Liang
Zhongshi Qiao
Zheng Wang
Lifeng Niu

Frontiers in Oncology

doi 10.3389/fonc.2024.1403762

1,163 views
1 citation

Case Report

Published on 14 Aug 2024

Immune-related intestinal pseudo-obstruction caused by immune checkpoint inhibitors: case report

in Cancer Immunity and Immunotherapy

Yimeng Qian
Zheng Zhi
Jing Ai
Lin Kang
Gang Qiu
Xin Huang
Jing Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1415117

1,482 views
4 citations